Impact of Family Pharmacist Intervention on Medication Adherence in Chronic Disease Patients: Mediated Effects Analysis Based on Community Pharmacy Data

被引:0
作者
Xia, Jing [1 ]
Jinshu, Huang [2 ]
Yanyan, Men [2 ]
Zhe, Jia [2 ]
机构
[1] School of Management, Qilu Medical University
关键词
Chronic Disease Patients; Community Pharmacy Data; Family Pharmacist Team; Mediating Effect; Medication Adherence;
D O I
10.4018/IJHISI.384615
中图分类号
学科分类号
摘要
This study evaluated the effectiveness of a family pharmacist team intervention on improving medication adherence among patients with chronic diseases. A total of 424 participants were randomly assigned to either an intervention group or a control group. The intervention group received structured support including medication guidance, health education, and self-management training for six months, while the control group received standard pharmacy services. Results showed that the intervention significantly improved medication adherence, with the average score rising from baseline after the intervention (6.89 versus 5.56), showing a large effect size (Cohen’s d = 0.98). Further analysis revealed that the improvement was partly mediated by enhanced health beliefs, increased medication knowledge, and better self-management ability, which together accounted for 68.8% of the total effect. These findings suggest that family pharmacist interventions can be an effective strategy for managing chronic diseases by addressing key psychological and behavioural factors. © 2025 IGI Global. All rights reserved.
引用
收藏
相关论文
共 26 条
[1]  
Emamipour S., van der Heijden A. A. W. A., Nijpels G., Elders P., Beulens J. W. J., Postma M. J., van Boven J. F. M., Feenstra T. L., A personalised screening strategy for diabetic retinopathy: A cost-effectiveness perspective, Diabetologia, 63, 11, pp. 2452-2461, (2020)
[2]  
Fan C. H., Hsu S. C., Hsiao F. H., Chang C. M., Liu C. Y., Lai Y. M., Chen Y. T., The association of social support and symptomatic remission among community-dwelling schizophrenia patients: A cross-sectional study, International Journal of Environmental Research and Public Health, 18, 8, (2021)
[3]  
Flood D., Edwards E. W., Giovannini D., Ridley E., Rosende A., Herman W. H., Jaffe M. G., DiPette D. J., Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool, Revista Panamericana de Salud Pública = Pan American Journal of Public Health, 46, (2023)
[4]  
Gabay G., Gere A., Zemel G., Moskowitz H., Personalized communication with patients at the emergency department: An experimental design study, Journal of Personalized Medicine, 12, 10, (2022)
[5]  
Jin Y., Lee Y. I., Liu B. F., Austin L., Kim S., How college students assess the threat of infectious diseases: Implications for university leaders and health communicators, Journal of International Crisis and Risk Communication Research, 4, 1, pp. 129-164, (2021)
[6]  
Kamran A., Ahari S. S., Biria M., Malpour A., Heydari H., Determinants of patient’s adherence to hypertension medications: Application of health belief model among rural patients, Annals of Medical and Health Sciences Research, 4, 6, pp. 922-927, (2014)
[7]  
Kirkegaard H., Taccone F. S., Skrifvars M., Soreide E., Postresuscitation care after out-of-hospital cardiac arrest: Clinical update and focus on targeted temperature management, Anesthesiology, 131, 1, pp. 186-208, (2019)
[8]  
Laraki Y., Bayard S., Decombe A., Capdevielle D., Raffard S., Preliminary evidence that fatigue contributes to anhedonia in stable individuals diagnosed with schizophrenia, Frontiers in Psychiatry, 14, (2023)
[9]  
Leucht S., Tardy M., Komossa K., Heres S., Kissling W., Davis J. M., Maintenance treatment with antipsychotic drugs for schizophrenia, Cochrane Database of Systematic Reviews, 5, (2012)
[10]  
Li Y. C., Bai W., Cai H., Wu Y., Zhang L., Ding Y. H., Yang J. J., Du X., Zeng Z. T., Lu C. M., Feng K. X., Mi W. F., Zhang L., Liu H. Z., Balbuena L., Cheung T., Su Z., An F. R., Xiang Y. T., Suicidality in clinically stable bipolar disorder and schizophrenia patients during the COVID-19 pandemic, Translational Psychiatry, 12, 1, (2022)